Biotricity (OTCMKTS:BTCY) Stock Price Down 1.9% – Here’s Why

Biotricity, Inc. (OTCMKTS:BTCYGet Free Report)’s share price fell 1.9% during mid-day trading on Wednesday . The company traded as low as $0.50 and last traded at $0.52. 42,159 shares changed hands during trading, a decline of 4% from the average session volume of 43,871 shares. The stock had previously closed at $0.53.

Biotricity Stock Down 1.9 %

The company has a market cap of $12.95 million, a PE ratio of -0.31 and a beta of 1.32. The stock’s 50 day moving average is $0.46 and its 200-day moving average is $0.37.

Biotricity (OTCMKTS:BTCYGet Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.06. The business had revenue of $3.62 million during the quarter, compared to the consensus estimate of $3.30 million. On average, analysts anticipate that Biotricity, Inc. will post -1.43 EPS for the current fiscal year.

Biotricity Company Profile

(Get Free Report)

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.

Featured Stories

Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with MarketBeat.com's FREE daily email newsletter.